ARTICLE | Company News
NICE wants more rifaximin data for hepatic encephalopathy
November 27, 2013 11:28 PM UTC
The U.K.'s NICE said it is "minded not to recommend" Targaxan rifaximin from Norgine B.V. (Amsterdam, the Netherlands) to reduce recurrence of episodes of overt hepatic encephalopathy (HE) in adults, ...